Akoya will join the Russell 3000® index to increase overall awareness and exposure to their investment community stock.
FREMONT, CA: According to a preliminary list of additions posted by FTSE Russell, Akoya Biosciences, Inc. (Akoya) will join the broad-market Russell 3000® Index after the 2021 Russell indexes annual reconstitution.
Membership in the US all-cap Russell 3000® Index, which is valid for one year, automatically qualifies the fund for inclusion in the large-cap Russell 1000® Index or the small-cap Russell 2000® Index, as well as the appropriate growth and value style indexes. FTSE Russell specifies membership in its Russell indexes primarily based on objective market-capitalization rankings and style characteristics.
“We are pleased Akoya is set to join the Russell 3000® index, and we believe this will increase the overall awareness of, and exposure to, our stock among the investment community,” says Brian McKelligon, Chief Executive Officer of Akoya. “Our inclusion follows the successful closing of our IPO in April, which raised $153.3 million in gross proceeds, and validates our commitment to increasing shareholder value and growing our spatial biology platform.”
Akoya Biosciences' mission as The Spatial Biology Company® is to bring context to the worlds of biology and human health through spatial phenotyping. The company provides comprehensive single-cell imaging solutions that enable researchers to phenotype cells spatially and visualize how they organize and interact to affect disease progression and response to treatment. In addition, Akoya's CODEX® and Phenoptics" platforms address the diverse needs of researchers conducting discovery, translational, and clinical research.
FTSE Russell is a leading global index provider that creates and manages a wide range of indexes, data, and analytical solutions for customer needs across asset classes, styles, and strategies. Covering 98 percent of the investment market, FTSE Russell indexes offer an accurate picture of global markets combined with expertise gained from developing local benchmarks around the world.